(ATR) AptarGroup - Ratings and Ratios

AptarGroup, Inc. (NYSE: ATR) is a global leader in the design and manufacturing of advanced drug delivery systems, consumer product dispensing solutions, and active material science technologies. The company serves a diverse range of industries, including pharmaceuticals, beauty, personal care, home care, and food and beverage. Through its three core segments—Aptar Pharma, Aptar Beauty, and Aptar Closures—it delivers innovative solutions that enhance the functionality and sustainability of packaging and delivery systems. Aptar Pharma specializes in respiratory and injectable solutions, such as metered dose inhaler valves for asthma and COPD, nasal spray pumps, and elastomeric components for syringes. Aptar Beauty focuses on dispensing solutions for the cosmetics and skincare industries, including pumps, closures, and aerosol valves. Aptar Closures provides tamper-evident, child-resistant, and dispensing closures for food, beverage, and household products. The company also invests in digital health solutions, integrating technology to improve patient outcomes and user experiences. With a strong global presence, AptarGroup operates manufacturing facilities and sales offices across Asia, Europe, Latin America, and North America, ensuring proximity to its customers and end markets. Founded in 1992 and headquartered in Crystal Lake, Illinois, AptarGroup is recognized for its commitment to innovation, sustainability, and quality.

From a technical perspective, AptarGroups stock (NYSE: ATR) is currently trading at $148.05, with a 20-day average volume of 310,836 shares. The stocks short-term trend, as indicated by the 20-day simple moving average (SMA), is slightly bullish at $144.69, while the 50-day SMA stands at $145.84, suggesting moderate upward momentum. However, the 200-day SMA of $154.20 indicates that the stock is trading below its long-term average, signaling potential resistance. The Average True Range (ATR) of 4.23 reflects moderate volatility, with price fluctuations expected to remain within a manageable range. Fundamentally, AptarGroups market capitalization is approximately $9.63 billion, with a price-to-earnings (P/E) ratio of 26.41 and a forward P/E of 26.04, indicating expectations of stable earnings growth. The price-to-book (P/B) ratio of 3.81 and the price-to-sales (P/S) ratio of 2.69 suggest that the stock is fairly valued relative to its book value and revenue. The return on equity (RoE) of 15.15% highlights the companys efficient use of shareholders capital.